Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Jul 4;295(6589):22–24. doi: 10.1136/bmj.295.6589.22

Live measles vaccine: a 21 year follow up.

C Miller
PMCID: PMC1246901  PMID: 3113599

Abstract

21 years after receiving Schwartz strain live measles vaccine 4500 trial participants showed a continuing high level of protection compared with those who were unvaccinated. Over the last seven years of the follow up no cases of measles were reported in vaccinated participants who had had close contact with the disease. Immunity induced by the vaccine seems to survive the challenge of close contact with measles in young children, even after 21 years.

Full text

PDF
22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Haas E. J., Wendt V. E. Atypical measles 14 years after immunization. JAMA. 1976 Aug 30;236(9):1050–1050. [PubMed] [Google Scholar]
  2. Hull H. F., Montes J. M., Hays P. C., Lucero R. L. Risk factors for measles vaccine failure among immunized students. Pediatrics. 1985 Oct;76(4):518–523. [PubMed] [Google Scholar]
  3. Sutherland I., Fayers P. M. Effect of measles vaccination on incidence of measles in the community. Br Med J. 1971 Mar 27;1(5751):698–702. doi: 10.1136/bmj.1.5751.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Walker D., Carter H., Jones I. G. Measles, mumps, and rubella: the need for a change in immunisation policy. Br Med J (Clin Res Ed) 1986 Jun 7;292(6534):1501–1502. doi: 10.1136/bmj.292.6534.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES